Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Trial of Toreforant (JNJ-38518168) in Moderate to Severe Plaque Psoriasis
2015-000277-12Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in plaque psoriasis and psoriasis comparing Toreforant arm with Placebo arm (2 arms). Primary endpoint: PASI 75 response at Week 12. Started Mar 2015; status: completed.
02
Drugs
toreforant
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on 2015-000277-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000277-12.